More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

INVESTORS

INVESTOR RELATIONS CONTACT

1 (858) 283-4016

[email protected]

ABOUT US

We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.

100+ SKUs

Across 12 Brands

40+ COUNTRY DISTRIBUTION

Health Authority Approval in Mexico and Brazil

$46.9M 2020 REVENUE

Margins Over 75%

6 COMPANIES IN PORTFOLIO

Serving Consumer, B2B, Pharmaceutical Markets

OUR HISTORY

What Makes Us A Company of Firsts®

MORE ABOUT US

Get to Know Our Team and Portfolio

STAY UP-TO-DATE WITH MJNA

PRESS RELEASES

See All

MEDIA COVERAGE

See All

STOCK INFO

LAST 0.0265 Change -0.0005
OPEN 0.0200 Change % 1.85%
HIGH 0.0287 52 Week Range 0.01-0.222
LOWW 0.0200 Day Range 0.0200-0.0287
VOLUME 15119948 Market Cap (real-time) N/A

Last Updated: 08-20-2021 (US/Eastern)

Subscribe for Company Updates

* indicates required

Follow us on

social networks

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.